Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemia

Published:2015-12 Issue:12 Volume:43 Page:1001-1014.e5
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Dolnikov Alla,Shen Sylvie,Klamer Guy,Joshi Swapna,Xu Ning,Yang Lu,Micklethwaite Kenneth,O'Brien Tracey A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference29 articles.

1. Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor;Jena;Blood,2010

2. Engineering T cells for cancer: Our synthetic future;Vonderheide;Immunol Rev,2013

3. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias;Brentjens;Blood,2011

4. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia;Brentjens;Sci Transl Med,2013

5. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N Engl J Med,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypermethylation of SOCS3 Affects the Prognosis of Children with Acute Lymphoblastic Leukemia and is Reversed by 5-aza-2′-deoxycytidine Through Inhibiting Cell Proliferation and Increasing Cell Apoptosis;J BIOL REG HOMEOS AG;2023

2. piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies;International Journal of Clinical Oncology;2023-03-02

3. Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study;Blood Cancer Journal;2022-07-07

4. Umbilical Cord Blood as a Source of Less Differentiated T Cells to Produce CD123 CAR-T Cells;Cancers;2022-06-28

5. The potential of cord blood to replenish young immune cells against cancer;Aging and Cancer;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3